Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.
about
Role of Imaging Techniques for Diagnosis, Prognosis and Management of Heart Failure Patients: Cardiac Magnetic Resonance.Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathyImproving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of thePrognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis.The case for CMR.Role of Cardiac MR Imaging in CardiomyopathiesReproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy.Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patientsExtracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trialDelayed enhancement cardiac computed tomography for the assessment of myocardial infarction: from bench to bedsideConnective tissue growth factor regulates cardiac function and tissue remodeling in a mouse model of dilated cardiomyopathyPrognostic Value of Pulmonary Vascular Resistance by Magnetic Resonance in Systolic Heart FailureDuchenne Muscular Dystrophy Mice and Men: Can Understanding a Genetic Cardiomyopathy Inform Treatment of Other Myocardial Diseases?Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis.Late Gadolinium Enhancement Amount As an Independent Risk Factor for the Incidence of Adverse Cardiovascular Events in Patients with Stage C or D Heart FailureChagas' heart disease: gender differences in myocardial damage assessed by cardiovascular magnetic resonance.Free Triiodothyronine Level Correlates with Myocardial Injury and Prognosis in Idiopathic Dilated Cardiomyopathy: Evidence from Cardiac MRI and SPECT/PET Imaging.Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging.Diagnostic and prognostic roles of echocardiography and cardiac magnetic resonanceMagnetic Resonance Imaging-Detected Myocardial Inflammation and Fibrosis in Rheumatoid Arthritis: Associations With Disease Characteristics and N-Terminal Pro-Brain Natriuretic Peptide Levels.Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment.Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophyPerformance of Cardiac Magnetic Resonance Imaging for Diagnosis of Myocarditis Compared with Endomyocardial Biopsy: A Meta-Analysis.Powerlessness of a Number: Why Left Ventricular Ejection Fraction Matters Less for Sudden Cardiac Death Risk Assessment.Late Gadolinium Enhancement on Cardiac MRI Correlates with QT Dynamicity Represented by QT/RR Relationship in Patients with Ventricular Arrhythmias.The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update.Cardiac magnetic resonance imaging: Which information is useful for the arrhythmologist?ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.Early detection of myocardial involvement by T1 mapping of cardiac MRI in idiopathic inflammatory myopathy.Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients with Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement.Right ventricular outflow tract dimensions in arrhythmogenic right ventricular cardiomyopathy/dysplasia-a multicentre study comparing echocardiography and cardiovascular magnetic resonance.Recurrent Syncope, a Clue in Amyloid Cardiomyopathy.Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study.
P2860
Q26829719-5401922E-F18C-492B-BD25-AAEFE6908F7EQ28067623-84698096-384D-47E6-8D30-504856D713DDQ28079620-AA77BDA9-70A2-4411-AE37-D705B78A0952Q28087002-5391BF1A-FA9B-4B24-ADA5-552EE8E83E1AQ30276294-5222588F-171D-4F8D-94BA-84F872B55E44Q30279054-D64C9E92-CD73-4741-BE0E-1C0B59294D7EQ30279246-FBD948D6-5C58-4352-BFB1-6848D2E6C833Q30376835-6293FA34-23FC-46E2-A87F-0B4059A59AE6Q33168755-7581D928-F9A9-4629-AA69-D2A5A730469FQ33727302-4B2B7698-82FB-4121-B529-D4C5680D5EACQ34130016-C342599E-CDAF-4753-B0A9-7A74BE772EC2Q34250674-323431D7-6189-4663-8A51-DBA2315997DBQ34817378-157DC55A-18A5-4DF5-AA59-CE6AC1FC9EDEQ35181260-9B65F0B2-EC30-44ED-A610-68BA7C150B75Q36379549-FE1DA354-889B-41DF-8CDC-945CC1855051Q36399795-EDA9948A-2E11-4E1F-BC43-9CC5DC3749A3Q36738249-B33D9DDE-A12B-4538-8898-A3EA6AEE47F9Q36760550-15D3BCF9-5F71-4629-B2F7-ABEA15972AEAQ37156444-4A0E6BB7-68CB-44D3-8C36-8B31EF05F09DQ37373426-3AC42A89-13F5-4894-B4DA-DBA1FF350D2BQ37444455-525226E0-9F2F-4E9D-9D98-905310F13FBFQ37526059-93702A1D-4E46-401E-A382-AE46C9A10DF4Q38659406-FD70F8DF-59E9-45C6-A686-4A75A74765DAQ38742921-63631ED3-9E9B-4E27-9FCC-3D13B45A2FBEQ38912706-65EFFA5E-BDC3-4245-83C1-1C25E20A8493Q39215532-16F1A3B9-0A87-48C7-BF57-5401DBF08827Q39388903-900C2F2D-1BA3-451E-BB6A-B5CF37CF1A61Q39410638-1B1B54F8-4F0C-4E78-943C-E50E252C6C3BQ41151699-A3F35274-5486-45CE-B530-9BEE65C85CB0Q41283268-87AC60C8-8801-4C22-912B-82B370FED080Q41637298-FD39DD8A-DA60-4037-8177-DCD4A2867890Q41646423-DB182930-08C3-4CE8-98F0-C9485F1EF318Q41693071-55514107-A384-4054-8396-0238933F1521Q46990439-18A809A9-066E-42DB-89F3-F30CD1A9BECCQ47801890-49274F3C-413C-4BCF-9DFA-E891C5D58A55Q47867796-F892ADC8-83A1-4DED-AE79-150C4F4F5101Q48505902-0C358CCA-AF3A-4A64-AFD6-415CE39B09B2Q50855137-AB763B49-C951-4011-9CA3-97DD19D90E01Q52645922-C70F92B5-2F82-4364-B3F5-20E136782DDCQ52877004-171BD63F-3024-4B4D-BE83-3D7737721AA1
P2860
Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Late gadolinium enhancement on ...... atic review and meta-analysis.
@ast
Late gadolinium enhancement on ...... atic review and meta-analysis.
@en
type
label
Late gadolinium enhancement on ...... atic review and meta-analysis.
@ast
Late gadolinium enhancement on ...... atic review and meta-analysis.
@en
prefLabel
Late gadolinium enhancement on ...... atic review and meta-analysis.
@ast
Late gadolinium enhancement on ...... atic review and meta-analysis.
@en
P2093
P2860
P31
P1476
Late gadolinium enhancement on ...... atic review and meta-analysis.
@en
P2093
Arabindra B Katwal
Michael J Lipinski
Nebiyu Adenaw
Sujith Kuruvilla
P2860
P304
P356
10.1161/CIRCIMAGING.113.001144
P577
2013-12-20T00:00:00Z